Chronic bronchitis is a form of chronic obstructive pulmonary disease (COPD) characterized by persistent productive cough and airway inflammation. It is defined clinically rather than anatomically and reflects long-term structural and inflammatory changes in the bronchial tree.
The condition develops gradually, most often in individuals with significant exposure to cigarette smoke or environmental pollutants.
For respiratory therapists, chronic bronchitis is highly relevant because it directly affects airway resistance, mucus clearance, ventilation, and oxygenation across outpatient, inpatient, and critical care settings.
What is Chronic Bronchitis?
Chronic bronchitis is defined as a productive cough lasting at least three months per year for two consecutive years, after other causes of chronic cough have been excluded. This definition emphasizes symptom duration rather than specific imaging or histologic findings.
The disease is characterized by chronic inflammation of the bronchi, enlargement of mucus-secreting glands, increased goblet cell production, and excessive mucus accumulation within the airways. Over time, these changes narrow airway lumens and increase airflow resistance.
Although chronic bronchitis is classified under chronic obstructive pulmonary disease, some individuals may meet clinical criteria for chronic bronchitis before spirometric evidence of persistent airflow limitation is present.
Pathophysiology of Chronic Bronchitis
The pathophysiologic processes in chronic bronchitis primarily involve the airways rather than the alveoli. Repeated exposure to irritants leads to persistent inflammation and structural remodeling of bronchial walls.
Airway Inflammation
Chronic exposure to tobacco smoke and other irritants stimulates infiltration of inflammatory cells, including neutrophils and macrophages, into the airway mucosa. These cells release mediators that perpetuate inflammation and contribute to tissue injury.
Persistent inflammation results in:
- Edema of the bronchial mucosa
- Thickening of airway walls
- Increased airway resistance
Note: These changes contribute to airflow obstruction and impaired ventilation.
Mucus Hypersecretion
One of the defining features of chronic bronchitis is excessive mucus production. Mucous glands enlarge, and goblet cells proliferate within the airway epithelium.
The Reid index, which measures the ratio of mucous gland thickness to total bronchial wall thickness, is often increased in chronic bronchitis. An elevated Reid index reflects glandular hypertrophy and hyperplasia.
Excess mucus can:
- Narrow airway lumens
- Obstruct smaller bronchioles
- Impair effective mucociliary clearance
- Increase susceptibility to infection
Note: Mucus plugging further worsens airflow limitation and contributes to ventilation-perfusion mismatch.
Airflow Limitation
Airflow limitation in chronic bronchitis results from a combination of inflammation, mucus obstruction, and airway wall thickening. Small airways are particularly vulnerable because they lack rigid structural support.
As airway resistance increases:
- Expiratory flow becomes limited
- Air trapping may develop
- Work of breathing increases
Note: Although alveolar destruction is not the primary feature, chronic bronchitis often coexists with emphysematous changes in many patients.
Ventilation-Perfusion Mismatch
Airway obstruction and mucus plugging create regions of the lung that are perfused but poorly ventilated. This leads to ventilation-perfusion mismatch and hypoxemia.
In advanced disease, chronic hypoxemia may trigger pulmonary vasoconstriction, increasing pulmonary vascular resistance and potentially leading to pulmonary hypertension and cor pulmonale.
Risk Factors
Cigarette Smoking
Cigarette smoking is the primary and most well-established risk factor for chronic bronchitis. Long-term exposure to tobacco smoke causes persistent irritation of the airway epithelium and impairs normal defense mechanisms, including mucociliary clearance. Repeated exposure leads to chronic inflammation, mucous gland enlargement, and excessive mucus production. The likelihood of developing chronic bronchitis increases with cumulative tobacco exposure, often quantified in pack-years.
Smoking also worsens symptom severity and increases the frequency of exacerbations. Importantly, smoking cessation can slow disease progression, reduce cough and sputum production, and improve overall respiratory health, even in patients with established disease.
Environmental and Occupational Exposures
Chronic inhalation of environmental irritants also contributes to the development of chronic bronchitis. Occupational exposure to dust, chemical fumes, vapors, and industrial pollutants can produce long-standing airway inflammation similar to that caused by smoking. In many parts of the world, exposure to biomass fuels used for indoor cooking and heating in poorly ventilated spaces is a major risk factor. Air pollution, particularly fine particulate matter, can further aggravate airway inflammation and increase the risk of symptom progression and exacerbations.
Recurrent Respiratory Infections
Repeated lower respiratory tract infections may worsen existing airway inflammation and contribute to structural airway changes. In susceptible individuals, recurrent infections can accelerate symptom progression and increase the likelihood of exacerbations. Over time, repeated inflammatory injury may compound the effects of other risk factors.
Genetic Susceptibility
Genetic factors may influence individual susceptibility to chronic bronchitis. While not as strongly linked as in certain forms of emphysema, genetic variability can affect inflammatory responses, mucus production, and repair mechanisms. These differences may partially explain why some individuals develop chronic bronchitis with similar environmental exposures while others do not.
Clinical Presentation
Chronic bronchitis typically develops slowly over many years. Early symptoms are often subtle, and patients may dismiss a persistent cough as a normal consequence of smoking or repeated respiratory infections.
Because of this gradual onset, diagnosis is frequently delayed until airflow limitation becomes more apparent or an acute exacerbation prompts medical evaluation.
Chronic Productive Cough
The defining symptom of chronic bronchitis is a persistent productive cough. Sputum production is present on most days and may be mucoid in stable disease. During acute exacerbations, sputum often increases in volume and may become purulent, reflecting infection or heightened inflammation.
Many patients report that cough is most prominent in the morning, likely due to accumulation of secretions overnight. Symptoms may also worsen during colder months, when viral infections and environmental triggers are more common.
Dyspnea
Shortness of breath develops as airway inflammation and mucus obstruction progress. In contrast to emphysema, where dyspnea may be an early feature, patients with chronic bronchitis often experience cough and sputum production for years before significant breathlessness occurs. As airflow limitation worsens, dyspnea may first appear with exertion and later occur during routine activities.
Wheezing
Airway narrowing and mucus plugging can generate wheezing, particularly during expiration. Wheezing may fluctuate in intensity and often worsens during exacerbations.
Physical Examination Findings
On physical examination, clinicians may detect coarse crackles and rhonchi caused by retained secretions. These sounds may improve after coughing. Wheezes and a prolonged expiratory phase reflect airflow obstruction. In advanced disease, signs of hyperinflation may be present.
Note: With longstanding hypoxemia and pulmonary hypertension, peripheral edema and other signs of right-sided heart failure may develop.
Diagnostic Evaluation
Accurate diagnosis of chronic bronchitis relies on clinical history supported by objective testing. Because the condition is defined by symptoms, diagnostic studies are used to confirm airflow limitation, assess severity, and exclude alternative causes.
Spirometry
Spirometry is essential for identifying airflow obstruction. A post-bronchodilator FEV1/FVC ratio less than 0.70 confirms persistent obstruction consistent with chronic obstructive pulmonary disease. The severity of impairment is further classified by the percent predicted FEV1.
In early chronic bronchitis, spirometry may remain normal despite a long-standing productive cough. As inflammation and airway narrowing progress, expiratory flow declines and obstructive patterns become evident. Repeated testing over time helps track disease progression and response to therapy.
Arterial Blood Gas Analysis
Arterial blood gas testing is useful in moderate to severe disease or during acute exacerbations. Hypoxemia may be present as ventilation-perfusion mismatch worsens. In advanced cases, chronic carbon dioxide retention can develop, leading to compensated respiratory acidosis. Monitoring gas exchange is particularly important in patients with signs of respiratory distress, altered mental status, or suspected ventilatory failure.
Imaging
Chest radiography may reveal increased bronchovascular markings or evidence of hyperinflation, but findings are often nonspecific. Imaging primarily helps exclude other conditions such as pneumonia, heart failure, or malignancy. High-resolution computed tomography can provide more detailed information, including airway wall thickening, mucus plugging, and structural changes in smaller airways.
Sputum Analysis
During acute exacerbations, sputum analysis can assist in identifying bacterial pathogens and guiding antibiotic selection. Changes in sputum color and volume often correlate with infectious triggers.
Management of Chronic Bronchitis
Chronic bronchitis is managed with the same overall goals used in chronic obstructive pulmonary disease: reduce symptoms, improve functional status, prevent exacerbations, and slow progression.
Because chronic bronchitis is strongly associated with mucus hypersecretion and impaired airway clearance, management also emphasizes secretion control, infection prevention, and patient self-management.
Smoking Cessation and Exposure Reduction
Stopping smoking is the most effective way to slow disease progression and reduce chronic cough and sputum production. Ongoing exposure to tobacco smoke and other inhaled irritants continues to drive airway inflammation and mucus hypersecretion.
Respiratory therapists support smoking cessation by:
- Assessing current use and readiness to quit
- Reinforcing how smoking affects symptoms and exacerbations
- Referring to counseling and pharmacologic options
- Following up during outpatient visits and hospital admissions
Note: Reducing occupational and environmental exposures is also important, particularly in patients exposed to dusts, fumes, or biomass smoke.
Pharmacologic Therapy
Medications for chronic bronchitis are used to reduce airway resistance, improve symptoms, and decrease exacerbation frequency.
Bronchodilators
Bronchodilators improve airflow by relaxing airway smooth muscle and reducing bronchomotor tone. Many patients with chronic bronchitis have some degree of bronchodilator responsiveness, even when obstruction is not fully reversible.
Common options include:
- Short-acting beta2-agonists for relief of intermittent symptoms
- Long-acting beta2-agonists for maintenance therapy
- Short- and long-acting anticholinergics to reduce bronchoconstriction and improve airflow
- Combination inhaled therapies for persistent symptoms
Note: Respiratory therapists ensure correct inhaler technique, assess the need for spacers or nebulized delivery, and monitor patient response.
Systemic Corticosteroids During Exacerbations
Systemic corticosteroids are not routinely recommended for stable chronic bronchitis but are commonly used during acute exacerbations to reduce airway inflammation, improve lung function, and shorten recovery time.
Note: Respiratory therapists monitor clinical response and support appropriate reassessment after treatment.
Antibiotics in Selected Exacerbations
Antibiotics are not recommended as routine maintenance therapy in stable chronic bronchitis. They are considered during exacerbations when bacterial infection is likely, particularly when sputum becomes purulent and symptoms worsen.
Note: Sputum cultures may be helpful in selected cases, especially in patients with severe disease or frequent exacerbations.
Vaccination and Infection Prevention
Respiratory infections are common triggers of exacerbations in chronic bronchitis. Preventive strategies include:
- Annual influenza vaccination
- Pneumococcal vaccination according to age and risk factors
- Practical infection control measures, such as hand hygiene and avoiding close contact with sick individuals
Note: Respiratory therapists help reinforce prevention and recognize early signs of deterioration.
Pulmonary Rehabilitation and Exercise Conditioning
Pulmonary rehabilitation improves exercise tolerance, reduces dyspnea perception, and improves quality of life. It does not reverse airflow obstruction, but it can improve the patient’s ability to perform activities of daily living.
In chronic bronchitis, rehabilitation is particularly useful because deconditioning often develops as patients limit activity due to symptoms.
RT contributions include:
- Teaching breathing control and pacing
- Supporting airway clearance strategies when needed
- Helping patients use bronchodilators and oxygen effectively during exercise
Airway Clearance and Secretion Management
Although airway clearance is not universally required for all COPD patients, it is often more relevant in chronic bronchitis because mucus hypersecretion and impaired clearance are central problems.
Approaches may include:
- Education on effective coughing and huff coughing
- Hydration and humidification when appropriate
- Bronchial hygiene techniques based on clinical assessment
- Coordinating treatments to optimize secretion mobilization, such as bronchodilator use before clearance sessions
Note: Respiratory therapists determine whether airway clearance interventions are likely to provide benefit and adjust the plan based on secretion burden and patient tolerance.
Chronic Bronchitis vs. Emphysema
Chronic bronchitis and emphysema are both forms of chronic obstructive pulmonary disease, but they differ in their primary pathophysiology and clinical features.
Chronic bronchitis primarily affects the airways and is defined by a persistent productive cough lasting at least three months per year for two consecutive years. It is characterized by chronic airway inflammation, mucous gland enlargement, and excessive mucus production, which lead to airflow obstruction and ventilation-perfusion mismatch.
Emphysema, in contrast, primarily affects the alveoli. It involves permanent enlargement of airspaces distal to the terminal bronchioles and destruction of alveolar walls, resulting in reduced surface area for gas exchange and loss of elastic recoil. Patients with emphysema often experience progressive dyspnea with less sputum production compared to those with chronic bronchitis.
Although the two conditions frequently coexist, chronic bronchitis is airway-dominant, while emphysema is alveolar-dominant in its structural and functional impact.
Acute Exacerbations of Chronic Bronchitis
Exacerbations are episodes of worsening respiratory symptoms beyond normal day-to-day variation. They often involve increased dyspnea, increased cough, increased sputum volume, and a change in sputum character.
Common Triggers
Frequent triggers include:
- Viral infections
- Bacterial infections
- Air pollution and inhaled irritants
- Poor adherence to maintenance therapy
Note: Exacerbations contribute to accelerated decline in lung function and increased risk of hospitalization.
Clinical Assessment
During an acute exacerbation, respiratory therapists assess:
- Work of breathing and accessory muscle use
- Oxygen saturation and response to supplemental oxygen
- Breath sounds, including wheezes and rhonchi
- Ability to cough and clear secretions
- Mental status changes that may suggest hypercapnia
Note: Arterial blood gases may be indicated in patients with severe hypoxemia, known hypercapnia, somnolence, or other signs of impending respiratory failure. Chest radiography may be used to exclude alternative diagnoses such as pneumonia, pneumothorax, or heart failure.
Treatment Principles
Treatment of acute exacerbations typically includes:
- Supplemental oxygen titrated to maintain SpO2 between 88% and 92%
- Short-acting bronchodilators, often delivered by nebulizer or metered-dose inhaler
- Systemic corticosteroids
- Antibiotics when sputum is purulent or infection is strongly suspected
Note: Respiratory therapists monitor response by tracking respiratory rate, heart rate, oxygenation, work of breathing, and symptom progression.
Noninvasive Ventilation
Noninvasive ventilation is indicated when exacerbations result in ventilatory failure with hypercapnia and acidemia. It can reduce work of breathing and improve alveolar ventilation, often preventing intubation.
RT responsibilities include:
- Selecting an appropriate interface and optimizing fit
- Adjusting inspiratory and expiratory pressures to support ventilation
- Ensuring adequate expiratory time to reduce air trapping
- Monitoring synchrony, tolerance, and gas exchange response
Note: The goal is improvement in pH and clinical status rather than immediate normalization of PaCO2.
Invasive Ventilation
Intubation and mechanical ventilation may be required when noninvasive ventilation is contraindicated or fails. Ventilator management must account for airway obstruction and air trapping.
Key principles include:
- Avoiding excessive respiratory rates
- Allowing sufficient expiratory time
- Monitoring for intrinsic PEEP
- Adjusting settings to reduce dynamic hyperinflation
Note: Patients with chronic bronchitis can be difficult to wean, so early planning for liberation from the ventilator is important.
Relevance to Respiratory Therapists
Chronic bronchitis is highly relevant to respiratory therapists because it involves airway obstruction, secretion burden, gas exchange impairment, and frequent exacerbations. These issues are central to respiratory care in both acute and chronic settings.
Respiratory therapists contribute by:
- Performing spirometry and ensuring high-quality testing
- Delivering bronchodilator therapy and optimizing inhaler technique
- Assessing oxygen needs and titrating therapy safely
- Implementing and evaluating secretion management strategies
- Recognizing ventilatory failure early and supporting NIV
- Educating patients on action plans, trigger avoidance, and adherence
Note: Respiratory therapists also play an important role in transitions of care by helping patients understand medications, devices, and warning signs that should prompt medical evaluation.
Chronic Bronchitis Practice Questions
1. What is chronic bronchitis?
Chronic bronchitis is a form of COPD characterized by chronic airway inflammation and a productive cough lasting at least 3 months per year for 2 consecutive years.
2. How is chronic bronchitis clinically defined?
By the presence of chronic productive cough for at least 3 months in each of 2 successive years, after excluding other causes.
3. What is the leading cause of chronic bronchitis?
Cigarette smoking
4. What historical nickname is given to patients with advanced chronic bronchitis?
“Blue bloater”
5. What arterial blood gas pattern is commonly seen in advanced chronic bronchitis?
Chronic compensated respiratory acidosis with hypoxemia.
6. Chronic bronchitis falls under which broader disease category?
Chronic obstructive pulmonary disease (COPD).
7. What type of ventilatory defect is seen in chronic bronchitis?
Obstructive lung disease
8. What is the primary pathophysiologic mechanism in chronic bronchitis?
Chronic airway inflammation with mucus hypersecretion leading to airflow obstruction.
9. Why is chronic bronchitis often diagnosed late?
Because symptoms develop gradually and patients may normalize chronic cough until an exacerbation occurs.
10. What are the hallmark symptoms of chronic bronchitis?
Chronic productive cough, sputum production, and progressive dyspnea.
11. What physical exam findings are common in chronic bronchitis?
Prolonged expiration, wheezing, rhonchi, crackles that may improve with coughing, and use of accessory muscles.
12. Why does cyanosis occur in advanced chronic bronchitis?
Persistent hypoxemia and secondary polycythemia.
13. What systemic findings may be present in advanced chronic bronchitis?
Peripheral edema, jugular venous distention, and signs of cor pulmonale.
14. What radiographic findings may be seen in chronic bronchitis?
Cardiomegaly, increased bronchovascular markings, and possible signs of hyperinflation.
15. What pulmonary function test findings are typical in chronic bronchitis?
Reduced FEV1, reduced FEV1/FVC ratio, and generally normal diffusing capacity (DLCO).
16. What hematologic abnormality may develop in chronic bronchitis due to chronic hypoxemia?
Secondary polycythemia
17. What ABG changes are seen during an acute exacerbation of chronic bronchitis?
Respiratory acidosis with hypoxemia and possible acute-on-chronic CO2 retention.
18. What airway clearance therapies are used in chronic bronchitis?
Chest physiotherapy and oscillatory positive expiratory pressure devices.
19. Which inhaled medications are commonly used in chronic bronchitis?
Short-acting and long-acting bronchodilators, including beta2-agonists and anticholinergics.
20. What are the primary management strategies for chronic bronchitis?
Smoking cessation, bronchodilator therapy, vaccination, pulmonary rehabilitation, and avoidance of irritants.
21. What factors influence prognosis in chronic bronchitis?
Smoking status, frequency of exacerbations, degree of airflow limitation, and comorbid conditions.
22. What auscultatory findings are typical in chronic bronchitis?
Rhonchi, wheezes, and coarse crackles.
23. What structural airway changes occur in chronic bronchitis?
Mucous gland enlargement, goblet cell hyperplasia, airway wall thickening, and mucus plugging.
24. What are the two major forms of bronchitis?
Acute bronchitis and chronic bronchitis.
25. What is acute bronchitis?
A short-term inflammation of the bronchi, usually due to viral infection, that resolves within weeks.
26. How does chronic bronchitis differ from acute bronchitis?
Chronic bronchitis is a long-term inflammatory condition with persistent cough, whereas acute bronchitis is temporary and typically infectious.
27. What is meant by “acute exacerbation of chronic bronchitis”?
A sudden worsening of respiratory symptoms beyond baseline, often triggered by infection.
28. What environmental factor most commonly triggers chronic bronchitis?
Long-term exposure to inhaled irritants, especially cigarette smoke.
29. How does chronic bronchitis impair gas exchange?
Airway narrowing and mucus plugging cause ventilation-perfusion mismatch and hypoxemia.
30. Which parts of the lung are primarily affected in chronic bronchitis?
The larger and smaller conducting airways, eventually involving peripheral bronchioles.
31. What long-term cardiovascular complication can develop from chronic bronchitis?
Cor pulmonale, or right-sided heart failure due to chronic pulmonary hypertension.
32. Is chronic bronchitis reversible?
No, the structural airway changes are irreversible, but symptoms and progression can be managed.
33. What is the key pathologic difference between emphysema and chronic bronchitis?
Emphysema involves alveolar destruction, whereas chronic bronchitis involves chronic airway inflammation and mucus hypersecretion.
34. How do respiratory infections affect patients with chronic bronchitis?
They commonly trigger acute exacerbations with worsening cough, sputum, and dyspnea.
35. When does cor pulmonale typically develop in chronic bronchitis?
In advanced stages due to prolonged hypoxemia and pulmonary hypertension.
36. What symptom is most characteristic of chronic bronchitis on physical examination?
Chronic productive cough
37. What is the typical appearance of sputum in chronic bronchitis?
Mucoid, and during infection it may become purulent or occasionally blood-streaked.
38. How does dyspnea typically progress in chronic bronchitis?
It begins gradually with exertion and may eventually occur at rest.
39. Which adventitious breath sound may improve after coughing?
Rhonchi caused by airway secretions.
40. When is long-term oxygen therapy indicated in chronic bronchitis?
When resting PaO2 is 55 mm Hg or less, or 59 mm Hg or less with evidence of cor pulmonale or polycythemia.
41. Why is the prognosis of chronic bronchitis considered variable?
Because disease progression differs based on smoking status, exacerbation frequency, and comorbidities.
42. What clinical findings suggest severe chronic bronchitis with cor pulmonale?
Peripheral edema, jugular venous distention, cyanosis, and elevated hemoglobin from secondary polycythemia.
43. In what population is chronic bronchitis most commonly diagnosed?
Adults over 40 years old with a history of significant smoking.
44. What are the primary causes of chronic bronchitis?
Cigarette smoking, chronic exposure to irritants, and recurrent respiratory infections.
45. What structural airway changes occur in chronic bronchitis?
Mucous gland enlargement, goblet cell hyperplasia, airway wall thickening, and mucus plugging.
46. What are common clinical manifestations of chronic bronchitis?
Chronic cough, excessive sputum production, dyspnea, and signs of fluid retention in advanced disease.
47. What diagnostic tools are commonly used to evaluate chronic bronchitis?
Clinical history, spirometry, chest radiography, and arterial blood gas analysis.
48. What chest x-ray findings may be seen in chronic bronchitis?
Increased bronchovascular markings and possible cardiomegaly.
49. What pulmonary function test pattern is typical in chronic bronchitis?
Reduced FEV1, reduced FEV1/FVC ratio, increased residual volume, and generally normal DLCO.
50. What ABG findings are common in advanced chronic bronchitis?
Elevated PaCO2 and decreased PaO2 with metabolic compensation in chronic cases.
51. What medication classes are commonly used to manage chronic bronchitis?
Bronchodilators, inhaled corticosteroids in selected patients, antibiotics for exacerbations, and supplemental oxygen when indicated.
52. Why must oxygen therapy be carefully titrated in chronic bronchitis?
To correct hypoxemia while minimizing the risk of worsening hypercapnia.
53. Does chronic bronchitis typically develop after a short-term viral infection?
No, that describes acute bronchitis, not chronic bronchitis.
54. What preventive measure is recommended annually for patients with chronic bronchitis?
Influenza vaccination, along with pneumococcal vaccination as indicated.
55. What other diseases are classified as obstructive lung diseases?
Asthma, emphysema, bronchiectasis, and cystic fibrosis.
56. What is the Reid index and how is it altered in chronic bronchitis?
The Reid index is the ratio of mucous gland thickness to total bronchial wall thickness, and it is increased (greater than 50%) in chronic bronchitis.
57. What does an elevated Reid index indicate?
Mucous gland hypertrophy and hyperplasia within the bronchial walls.
58. Which inflammatory cells are most commonly involved in chronic bronchitis?
Neutrophils, macrophages, and lymphocytes.
59. How does chronic bronchitis impair mucociliary clearance?
Excess mucus production and ciliary dysfunction reduce effective clearance of secretions.
60. Why are small airways particularly vulnerable in chronic bronchitis?
Because inflammation and mucus accumulation easily narrow their already small lumens.
61. What is the primary cause of ventilation–perfusion mismatch in chronic bronchitis?
Poor ventilation of perfused alveoli due to airway narrowing and mucus plugging.
62. During which season do chronic bronchitis symptoms commonly worsen?
Winter months, often due to increased respiratory infections.
63. What happens to airway resistance in chronic bronchitis?
Airway resistance increases due to inflammation and mucus obstruction.
64. Can spirometry appear normal in early chronic bronchitis?
Yes, airflow obstruction may not be evident until the disease progresses.
65. What is a common cause of hospitalization in chronic bronchitis?
Acute exacerbation with worsening dyspnea, hypoxemia, and possible infection.
66. What is the primary effect of bronchodilators in chronic bronchitis?
They decrease airway resistance and improve airflow.
67. Are systemic corticosteroids routinely used in stable chronic bronchitis?
No, they are primarily used during acute exacerbations.
68. What sputum change suggests a bacterial exacerbation?
Increased volume and purulence of sputum.
69. What oxygen saturation range is generally targeted during acute exacerbation?
An SpO2 between 88% and 92%.
70. What long-term complication may result from chronic hypoxemia in chronic bronchitis?
Pulmonary hypertension
71. How does chronic bronchitis increase the work of breathing?
Airway narrowing and mucus plugging increase airflow resistance.
72. What bedside sign may suggest hypercapnia in chronic bronchitis?
Confusion, drowsiness, or somnolence.
73. Why are patients with chronic bronchitis prone to recurrent respiratory infections?
Excess mucus and impaired clearance promote bacterial growth.
74. What is the goal of pulmonary rehabilitation in chronic bronchitis?
To improve exercise capacity, reduce dyspnea, and enhance quality of life.
75. How does chronic bronchitis differ pathologically from emphysema?
Chronic bronchitis primarily involves airway inflammation and mucus hypersecretion, whereas emphysema involves alveolar destruction.
76. Which airway structure primarily undergoes hypertrophy in chronic bronchitis?
The submucosal mucous glands enlarge due to chronic irritation and inflammation.
77. What epithelial change contributes to excessive mucus production in chronic bronchitis?
Goblet cell hyperplasia increases mucus secretion within the bronchial epithelium.
78. How does chronic bronchitis affect expiratory airflow?
It reduces expiratory flow because of airway narrowing, inflammation, and mucus obstruction.
79. What is a common early symptom before significant dyspnea develops in chronic bronchitis?
A persistent productive cough, often worse in the morning.
80. Why does chronic bronchitis increase the risk of atelectasis?
Mucus plugging can obstruct bronchioles, leading to collapse of distal alveoli.
81. What physiologic change contributes to air trapping in chronic bronchitis?
Premature airway closure during expiration.
82. What is the primary cause of wheezing in chronic bronchitis?
Airflow through narrowed, inflamed, and mucus-filled airways.
83. How does adequate hydration benefit patients with chronic bronchitis?
It helps thin secretions, making them easier to expectorate.
84. What role can humidification play in managing chronic bronchitis?
It helps maintain airway moisture and may support mucus clearance.
85. Why must oxygen therapy be carefully monitored in some patients with chronic bronchitis?
Excessive oxygen can worsen hypercapnia in patients with chronic CO2 retention.
86. What laboratory finding may suggest chronic hypoxemia in chronic bronchitis?
Elevated hemoglobin and hematocrit levels due to secondary polycythemia.
87. How does chronic bronchitis contribute to increased pulmonary vascular resistance?
Chronic hypoxic vasoconstriction raises resistance in the pulmonary circulation.
88. What symptom change often signals an impending exacerbation?
An increase in sputum volume or a change in sputum color to purulent.
89. Why are written action plans important for patients with chronic bronchitis?
They help patients recognize early signs of worsening disease and seek timely treatment.
90. What ventilator adjustment can help reduce air trapping in mechanically ventilated patients with chronic bronchitis?
Prolonging expiratory time by lowering respiratory rate or adjusting the I:E ratio.
91. What is intrinsic PEEP and why is it clinically relevant in chronic bronchitis?
Intrinsic PEEP is pressure from trapped air at end expiration, which increases the work of breathing.
92. How does chronic bronchitis affect exercise tolerance?
Airflow limitation and hypoxemia reduce endurance and increase exertional dyspnea.
93. Why are patients with chronic bronchitis at risk for frequent hospital readmissions?
Recurrent exacerbations and incomplete recovery between episodes contribute to instability.
94. What auscultatory finding may indicate retained secretions?
Rhonchi that partially or completely clear after coughing.
95. What is the primary role of anticholinergic bronchodilators in chronic bronchitis?
They reduce bronchoconstriction and improve airflow.
96. Why is early smoking cessation essential in chronic bronchitis?
It slows the progression of airway inflammation and decline in lung function.
97. What complication related to fluid balance may occur in advanced chronic bronchitis?
Peripheral edema due to right-sided heart failure (cor pulmonale).
98. How does chronic bronchitis impact quality of life?
Persistent cough, sputum production, and dyspnea can significantly limit daily activities.
99. What is the effect of repeated exacerbations on lung function in chronic bronchitis?
They accelerate the decline in FEV1 over time.
100. What is the overall goal of chronic bronchitis management?
To reduce symptoms, prevent exacerbations, and preserve lung function and quality of life.
Final Thoughts
Chronic bronchitis is defined by a persistent productive cough caused by chronic airway inflammation, enlargement of mucous glands, and impaired mucociliary clearance. These changes narrow the airways, increase resistance, and contribute to ventilation-perfusion mismatch.
As the condition advances, patients may develop chronic hypoxemia, carbon dioxide retention, and frequent exacerbations that accelerate lung function decline.
Respiratory therapists are integral to management in both outpatient and acute care settings. They conduct and interpret pulmonary function tests, optimize inhaled therapy delivery, titrate oxygen safely, and assist with ventilatory support when necessary. They also teach airway clearance techniques, reinforce avoidance of irritants, and support early recognition of symptom worsening to help prevent hospitalizations.
Written by:
John Landry is a registered respiratory therapist from Memphis, TN, and has a bachelor's degree in kinesiology. He enjoys using evidence-based research to help others breathe easier and live a healthier life.
References
- Widysanto A, Goldin J, Mathew G. Chronic Bronchitis. [Updated 2025 Feb 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.